The 4th European Course of in vivo Preclinical Assays in Cancer Therapy is an extensive training programme designed to educate and update the biomedical research community on current trends and technological advances in in vivo preclinical assays in cancer.
This course focuses mainly on use of tumour xenograft in mice and genetic engineered mouse models in anticancer drug testing context, including also antitumor immune response study, pharmacology and ethics. Experience of industrial pharmaceutical reserarch will complete this session.
Virginie Dangles-Marie, Elisabetta Marangoni and Sergio Roman-Roman
Includes course material, lunches, coffee breaks and social dinner.
Academic: 300 euros (VAT included)
Industry: 450 euros (VAT included)
